Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML
Clinical trial NCT02875093 · TERMINATED
Trial details
- NCT number
- NCT02875093
- Sponsor
- Polaris Group
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-20
- Primary completion
- 2019-07-10
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.